Girls Are Getting The HPV Vaccine, But Disparities Persist

When it comes to vaccinating adolescent females against human papillomavirus (HPV), the most common sexually transmitted disease known to be the main cause of cervical cancer, Connecticut boasts a slightly higher participation rate than the national average. About 58 percent of females in the state received the initial HPV vaccine dose compared with roughly 54 percent nationally, according to the National Immunization Survey, based on data from 2012 for girls aged 13-17. HPV vaccine is given in three shots and Connecticut has a completion rate of 44 percent, better than the national average of 33 percent, according to the survey.  The U.S. Centers for Disease Control and Prevention recently reported that the number of girls receiving the HPV vaccine nationally lags behind other vaccination rates and has “not moved forward.’’

The state’s rate is “probably due to a combination of factors,” said Linda Niccolai, an associate professor of epidemiology at the Yale School of Public Health and director of the HPV-Impact Project at the Yale Emerging Infections Program. “Health insurance coverage and rates are pretty good in Connecticut, but it’s also possible that providers in Connecticut are more proactive in making sure their patients are vaccinated and parents are more aware of the need for the vaccination.”

The national data show that Hispanic females have the highest participation rate at 63 percent, followed by whites at 51 percent, and blacks at 50 percent.

More about: , , , , , , ,